Drug Profile
Research programme: prostaglandin D2 receptor antagonists - Atopix Therapeutics
Alternative Names: ATX2286Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Oxagen
- Class Small molecules
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Hypersensitivity; Inflammation; Respiratory tract disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Allergy in United Kingdom (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Asthma in United Kingdom (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in United Kingdom (PO)